CAS: 57982-77-1; (S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-Imidazol-5-yl)Methyl)-6-((1H-Indol-3-yl)Methyl)-15-(Tert-Butoxymethyl)-21-(3-((Diaminomethylene)Amino)Propyl)-12-(4-Hydroxybenzyl)-9-(Hydroxymethyl)-18-Isobutyl-1,4,7,10,13,16,19-Heptaoxo-1-((S)-5-Oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-Heptaazadocosan-22-Oyl)-N-Ethylpyrrolidine-2-Carboxamide

该化合物是一种合成的脱脂激素(GnRH)模拟物,主要用于与激素调节有关的医疗应用,主要用于激素调节医疗应用;它作为GnRH受体的强力刺激剂,刺激垂体性腺,随后释放润滑性激素(LH)和泡泡激素(FSH),可以用于各种治疗环境,包括治疗对激素敏感的癌症(如前列腺癌)和辅助生殖技术.Buserelin的特点是有能力通过持续管理来降低GnRH受体,导致性激素水平下降.该物质通常通过注射进行施用,其半衰期相对较短,需要小心下药.其化学结构包括一个具体序列的氨酸,以激发其生物活动,并被归类为一种浸泡激素.与任何药物一样,潜在的副作用可能包括荷尔蒙失衡和注射场反应,强调其使用期间医疗监督的重要性.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    Pglu-His-Trp-Ser-Tyr(Bzl)-D-Ser(Tbu)-Leu-Arg(No2)-Pro-Nhet置于5% Palladium Over Charcoal 氢气体系中,用 N,N-二甲基甲酰胺 作为反应溶剂,化学反应生成 布舍瑞林
    参考文献:Methods For The Production Of Peptide Derivatives
    标题:Methods For The Production Of Peptide Derivatives
    摘要:这项发明涉及一种通过固相合成和后组装溶液相合成相结合的方法制备c-末端酰胺衍生物的肽.这些c-末端酰胺衍生物的肽进一步转化为肽醋酸酯.该发明还涉及纯肽醋酸酯和受保护的肽前体.

    海关参考信息

    专利信息


    专利号:US-12383499-B2
    优先权日:2018-01-01
    标题:Scale up synthesis of silicasome nanocarriers
    发明人:NEL ANDRE E; MENG HUAN; LIU XIANGSHENG
    权利人:UNIV CALIFORNIA
    摘要:In order to facilitate the approval and commercialization of silicasome drug delivery systems (e.g. irinotecan silicasomes) it is necessary to scale up synthesis of the drug-loaded silicasomes. In this regard, it was discovered that the synthesis protocols used for laboratory synthesis of drug-loaded silicasomes (e.g., 500 mg/batch) do not scale to large scale silicasome production, because the resulting products were too heterogeneous for use as pharmaceuticals. Accordingly, new methods are provided herein that effectively afford the large-scale production of mesoporous silica nanoparticles (MSNPs) and lipid bilayer coated MSNPs (silicasomes).

    专利号:US-7714063-B2
    优先权日:2007-11-15
    标 题 :Solid support for Fmoc-solid phase synthesis of peptides
    发明人:SRIVASTAVA KRIPA SHANKER; DAVIS MATTHEW RYAN
    权利人:MALLINCKRODT INC
    摘要:The present invention provides compositions and processes for the solid phase synthesis of polypeptides. In particular, the present invention provides solid supports and processes for preparing solid supports for the synthesis of polypeptides.

    专利号:US-12351573-B2
    优先权日:2019-05-09
    标 题:Compounds for use in synthesis of peptidomimetics
    发明人:AL-ABED YOUSEF; CHENG KAI FAN
    权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
    摘要:Synthesis of O-benzotriazole and O-imidazole synthons are described. Uses of synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the synthons and uses of azapeptides and other peptidomimetics are also described.

    专利号:US-2023159450-A1
    优先权日:2020-05-08
    标 题 :Dimers for use in synthesis of peptidomimetics
    发明人:AL-ABED YOUSEF; ALTITI AHMAD
    权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
    摘要:Dimers for use in synthesis of peptidomimetics are described. Uses of dimers as synthons in synthesis of azapeptides and other peptidomimetics, azapeptides and other peptidomimetics synthesized from the dimers and uses of azapeptides and other peptidomimetics are also described.

    专利号:EP-0443532-B1
    优先权日:1990-02-20
    标题:Temporary minimal protection synthesis of LH-RH analogs
    发明人:NESTOR JOHN J JR; MCCLURE NATALIE L
    权利人:SYNTEX INC
    摘要:A solid phase synthesis of LH-RH analogs in which the amino acids serine and histidine, if present, are side chain protected during the synthesis with groups labile to selected alpha -amino or deprotecting agents.

    专利号:US-5212288-A
    优先权日:1990-02-20
    标 题:Temporary minimal protection synthesis of serine-containing polypeptides
    发明人:NESTOR JR JOHN J; MCCLURE NATALIE L; ARZENO HUMBERTO
    权利人:SYNTEX INC
    摘要:In a process for the solid phase synthesis of a polypeptide containing at least one serine residue, the improvement comprising temporarily protecting the side chain of the serine residue with a protecting group which is removed immediately following the addition of the serine to the peptide chain.
    杭州阿诺生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.adlainortye.com
    电话: 0571-28918366👤
    📞杭州阿诺生物医药科技有限公司 ⚠️参考联系方式

    销售电话:0571-28918366
    邮箱:info@adlainortye.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海正极生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bioplus.com.cn
    电话: 021-64847500👤
    📞上海正极生物科技有限公司 ⚠️参考联系方式

    销售电话:021-64847500
    邮箱:sales@bioplus.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Wittke M, Drillich M, Tenhagen BA, Heuwieser W. [Comparision of ovulation synchronization (OVSYNCH) with the selective induction of oestrus using PGF2alpha after rectal palpation in a dairy herd]. Dtsch Tierarztl Wochenschr. 2005 Oct;112(10):368–74.
    参考文献:10.1016/j.theriogenology.2011.05.020
    摘要:Vicente JS, Lavara R, Marco-Jiménez F, Viudes-de-Castro MP. Detrimental effect on availability of buserelin acetate administered in seminal doses in rabbits. Theriogenology. 2011 Oct 01;76(6):1120–5. doi: 10.1016/j.theriogenology.2011.05.020.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知